Supported by SCHARP’s data management, HIV Prevention Trials Network shows 96 percent reduction in HIV transmission to uninfected sexual partners
May 23, 2011
Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners by starting oral antiretroviral therapy, according to findings from a large multinational clinical study conducted by the HIV Prevention Trials Network, a global partnership dedicated to reducing the transmission of HIV through biomedical, behavioral, and structural interventions.
SCHARP data shows longer nevirapine treatment reduces infection by half for babies with HIV-infected mothers, 75 percent for infants of untreated moms
March 14, 2011
Giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug daily for six weeks, according to preliminary clinical trial data presented March 2 at the Retroviruses and Opportunistic Infections conference in Boston.
The Fred Hutchinson Cancer Research Center’s Dr. Catherine Blish is the recipient of an Interscience Conference on Antimicrobial Agents and Chemotherapy Young Investigator Award from the American Society for Microbiology for her work elucidating the role of neutralizing antibodies in HIV transmission.
Antiretroviral therapy associated with 92 percent decreased risk of HIV transmission among HIV-1 discordant couples in large, multinational study
June 1, 2010
Research led by Dr. Deborah Donnell of the Vaccine and Infectious Disease Institute at the Fred Hutchinson Cancer Research Center has found that treating HIV-infected persons with antiretroviral therapy (ART) reduces HIV transmission to their sexual partners by more than 90 percent.
VIDI’s Elizabeth Brown studies mother-to-child transmission of HIV and more to make a difference in peoples’ lives
June 22, 2009
| By Rachel Tompa
From mother-to-child transmission of HIV to coronary artery lesions, Dr. Elizabeth Brown of the Fred Hutchinson Cancer Research Center loves a statistical challenge. And the more uncertain, the better—that’s where she believes good statistics can really make a difference.